524604 — Adline Chem Lab Balance Sheet
0.000.00%
- IN₹73.53m
- IN₹88.96m
Annual balance sheet for Adline Chem Lab, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.523 | -1.57 | 0.469 | 0.617 | 0.422 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 15.2 | 16.4 | 1.23 | 0 | 0 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 27.7 | 19.8 | 4.33 | 0.617 | 0.422 |
Net Property, Plant And Equipment | 1.17 | 0 | 0 | 0 | 0 |
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Total Assets | 75.8 | 56.3 | 48.7 | 0.617 | 0.422 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 40.2 | 33 | 19.3 | 13.4 | 15 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 43.7 | 37 | 22.3 | 16.3 | 17.6 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 32.1 | 19.3 | 26.5 | -15.7 | -17.1 |
Total Liabilities & Shareholders' Equity | 75.8 | 56.3 | 48.7 | 0.617 | 0.422 |
Total Common Shares Outstanding |